D. Cirillo (Milano, Italy), G. Sotgiu (Sassari, Italy)
The comparison of tuberculin skin test and quantiferon TB gold test in latent tuberculosis infection in health workers
F. Ciftci, E. Bozkanat, O. Sezer, H. Kaya, B. Mesut, Z. Kartaloglu (Istanbul, Turkey)
|   |
Interferon-γ- essay (IGRA) in the diagnosis of non-pulmonary tuberculosis
N. Buitenweg, B. Kwa (Amsterdam, Netherlands)
| |
The effect of IFN-gamma on disease severity in pericardial tuberculosis
J. Wolske, K. van Veen, F. Syed, J. Russell, K. Tibazarwa, M. Ntsekhe, B. Mayosi, R. Wilkinson, K. Wilkinson (Cape Town, South Africa; Borstel, Germany)
| |
Outcome following an ²indeterminate² QuantiFERON®-TB gold test in suspected tuberculosis
R. Dharmagunawardena, S. Mufti, H. Branley (London, United Kingdom)
| |
Interpretation of TB-specific interferon gamma assays (T.SPOT-TB & QFT-GIT) in South Africa: boosting, reproducibility and the effect of lymphocyte count normalisation
R. van Zyl-Smit, K. Peprah, J. Kiek, R. Dawson, E. Bateman, K. Dheda (Cape Town, South Africa)
| |
Latent tuberculosis: diagnostic and treatment
V. Pencheva, O. Georgiev, D. Petrova, D. Baltajieva (Sofia, Bulgaria)
| |
Performance of quantiferon test in screening for latent tuberculous infection in rheumatoid arthritis patients undergoing anti-TNF therapy
D. Boisteanu, C. Ancuta, R. Chirieac, C. Tacu, E. Ancuta, R. Vasiluta, R. Miron, C. Archip (Iasi, Romania)
| |
Impaired Mtb-specific alveolar T-cell responses in HIV+ persons with latent TB infection
B. Kalsdorf, T. Scriba, K. Wood, K. Wilkinson, P. Mouton, K. Skolimowska, K. Dheda, R. Dawson, M. Ernst, W. Hanekom, C. Lange, R. Wilkinson (Cape Town, South Africa; Borstel, Germany; London, United Kingdom)
| |
Programmatic experience with QuantiFERON-TB gold in-tube assay for contact screening in congregate settings in Singapore
S. H. Gan, M. Pushparani, K. W. KhinMar, T. M. Barkham, J. Cutter, L. James, Y. T. Wang, C. B. E. Chee (Singapore, Singapore)
| |
Comparison of the sensitivity and specificity of two whole blood interferon-gamma assays for M. tuberculosis infection
N. Harada, K. Higuchi, T. Yoshiyama, Y. Kawabe, A. Fujita, Y. Sasaki, M. Horiba, S. Mitarai, M. Yonemaru, H. Ogata, H. Ariga, A. Kurashima, A. Wada, M. Takamori, F. Yamagishi, K. Suzuki, T. Mori, N. Ishikawa (Kiyose City, Tokyo, Fuchu City, Tokyo, Chiba C
| |
Contribution of a whole blood IFN-gamma release assay for diagnosis of M. tuberculosis infection in BCG-vaccinated children
R. Drenska, P. Minchev, Y. Todorova, R. Markova (Sofia, Bulgaria)
| |
Kinetics of an interferon-γ release assay in military personnel with a positive tuberculin skin test
N. Schlosser, S. van Brummelen, A. Bauwens (Utrecht, Netherlands)
| |
The role of quantiferon tuberculosis gold test (Q) in diagnosing active tuberculosis (TB) and latent tuberculosis infection (LTI) in children
D. Alexandrescu, B. Torok, E. Barbu (Brasov, Romania)
| |
Interferon-γ released assay (IGRA) in Greek patients with sarcoidosis
A. Gogali, M. Matthaiou, I. Margelis, K. Gartzonika, M. Nikolopoulou, S. Katsenos, G. Daskalopoulos, S. Constantopoulos, A. Mavridis (Ioannina, Greece)
| |
Kinetics of plasma osteopontin during treatment in patients with pulmonary tuberculosis. A preliminary study
B. Grigoriu, B. Moldoveanu, M. Enache, D. Simion, S. Arama, D. Gramada (Iasi, Romania)
| |
Impaired host defense against Mycobacterium avium in mice with chronic granulomatous disease
M. Fujita, I. Inoshima, E. Harada, H. Ouchi, S. Ikegame, Y. Nakanishi, K. Watanabe (Fukuoka, Japan)
| |
A patient with miliary BCG-tuberculosis and a positive ELISPOT-PPD on BAL fluid
M. Quanjel, S. Thijsen, J. Bouwman, A. Bossink (Utrecht, Netherlands)
| |
Evaluation of TB antibodies using ELISA and M. tuberculosis DNA using PCR in children and adolescents from high-prevalence regions
O. V. Kasimtseva (Moscow, Russian Federation)
| |
Comparation of QFT-GIT test and tubeculine skin test in patients with sarcoidosis
E. Makas, G. Ortakoylu, A. Bahadir, F. Alkan, E. Caglar (Istanbul, Turkey)
| |